6-156778847-GGGCGGCGGCGGC-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001374828.1(ARID1B):​c.1182_1193delCGGCGGCGGCGG​(p.Gly395_Gly398del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000912 in 1,403,380 control chromosomes in the GnomAD database, including 1 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000095 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000091 ( 1 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 4.68

Publications

1 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778847-GGGCGGCGGCGGC-G is Benign according to our data. Variant chr6-156778847-GGGCGGCGGCGGC-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445786.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000908 (114/1255558) while in subpopulation SAS AF = 0.00041 (24/58574). AF 95% confidence interval is 0.000282. There are 1 homozygotes in GnomAdExome4. There are 55 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1182_1193delCGGCGGCGGCGG p.Gly395_Gly398del disruptive_inframe_deletion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1182_1193delCGGCGGCGGCGG p.Gly395_Gly398del disruptive_inframe_deletion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.0000947
AC:
14
AN:
147822
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000199
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000214
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000751
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000540
AC:
3
AN:
55508
AF XY:
0.0000609
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000908
AC:
114
AN:
1255558
Hom.:
1
AF XY:
0.0000891
AC XY:
55
AN XY:
617162
show subpopulations
African (AFR)
AF:
0.000283
AC:
7
AN:
24704
American (AMR)
AF:
0.000352
AC:
6
AN:
17062
Ashkenazi Jewish (ASJ)
AF:
0.0000490
AC:
1
AN:
20424
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27604
South Asian (SAS)
AF:
0.000410
AC:
24
AN:
58574
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42440
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5046
European-Non Finnish (NFE)
AF:
0.0000694
AC:
70
AN:
1008990
Other (OTH)
AF:
0.000118
AC:
6
AN:
50714
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000947
AC:
14
AN:
147822
Hom.:
0
Cov.:
29
AF XY:
0.0000970
AC XY:
7
AN XY:
72166
show subpopulations
African (AFR)
AF:
0.000199
AC:
8
AN:
40194
American (AMR)
AF:
0.00
AC:
0
AN:
14996
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4882
South Asian (SAS)
AF:
0.000214
AC:
1
AN:
4664
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9854
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
300
European-Non Finnish (NFE)
AF:
0.0000751
AC:
5
AN:
66596
Other (OTH)
AF:
0.00
AC:
0
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jun 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B: BP3, BS2 -

ARID1B-related disorder Benign:1
Mar 02, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Sep 21, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.7
Mutation Taster
=177/23
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779747; hg19: chr6-157099981; COSMIC: COSV99034253; API